TR199902117T2 - (E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-�ndol-2-karboksilik asidin kristalimsi hidratlanm�� sodyum tuzu. - Google Patents

(E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-�ndol-2-karboksilik asidin kristalimsi hidratlanm�� sodyum tuzu.

Info

Publication number
TR199902117T2
TR199902117T2 TR1999/02117T TR9902117T TR199902117T2 TR 199902117 T2 TR199902117 T2 TR 199902117T2 TR 1999/02117 T TR1999/02117 T TR 1999/02117T TR 9902117 T TR9902117 T TR 9902117T TR 199902117 T2 TR199902117 T2 TR 199902117T2
Authority
TR
Turkey
Prior art keywords
sodium salt
phenylpyrrolidin
indole
dichloro
oxo
Prior art date
Application number
TR1999/02117T
Other languages
English (en)
Turkish (tr)
Inventor
Cimarosti Zadeo
Maragni Paolo
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of TR199902117T2 publication Critical patent/TR199902117T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
TR1999/02117T 1997-03-05 1998-03-03 (E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-�ndol-2-karboksilik asidin kristalimsi hidratlanm�� sodyum tuzu. TR199902117T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9704498.6A GB9704498D0 (en) 1997-03-05 1997-03-05 Chemical compound

Publications (1)

Publication Number Publication Date
TR199902117T2 true TR199902117T2 (xx) 2000-03-21

Family

ID=10808697

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02117T TR199902117T2 (xx) 1997-03-05 1998-03-03 (E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-�ndol-2-karboksilik asidin kristalimsi hidratlanm�� sodyum tuzu.

Country Status (29)

Country Link
EP (1) EP0966463A1 (et)
JP (1) JP2001513796A (et)
KR (1) KR20000075907A (et)
CN (1) CN1249750A (et)
AP (1) AP9901637A0 (et)
AR (1) AR011178A1 (et)
AU (1) AU6825198A (et)
BG (1) BG103779A (et)
BR (1) BR9808305A (et)
CA (1) CA2282851A1 (et)
CO (1) CO4940415A1 (et)
EA (1) EA199900710A1 (et)
EE (1) EE9900387A (et)
GB (1) GB9704498D0 (et)
HR (1) HRP980114A2 (et)
HU (1) HUP0002109A2 (et)
ID (1) ID24207A (et)
IL (1) IL131489A0 (et)
IS (1) IS5166A (et)
NO (1) NO994303L (et)
NZ (1) NZ337315A (et)
OA (1) OA11154A (et)
PE (1) PE51399A1 (et)
PL (1) PL335652A1 (et)
SK (1) SK119699A3 (et)
TR (1) TR199902117T2 (et)
WO (1) WO1998039327A1 (et)
YU (1) YU43499A (et)
ZA (1) ZA981791B (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
GB9825988D0 (en) 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
RU2020100230A (ru) 2017-06-12 2021-07-13 Глитек Ллс. Лечение депрессии антагонистами nmda и антагонистами d2/5-ht2a или селективными антагонистами 5-нт2a

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
PE51399A1 (es) 1999-06-07
IL131489A0 (en) 2001-01-28
NO994303L (no) 1999-11-03
EA199900710A1 (ru) 2000-04-24
BR9808305A (pt) 2000-05-16
EE9900387A (et) 2000-04-17
ID24207A (id) 2000-07-13
HUP0002109A2 (hu) 2001-04-28
SK119699A3 (en) 2000-05-16
IS5166A (is) 1999-08-27
PL335652A1 (en) 2000-05-08
AU6825198A (en) 1998-09-22
OA11154A (en) 2003-04-16
CN1249750A (zh) 2000-04-05
NZ337315A (en) 2001-02-23
BG103779A (en) 2000-06-30
HRP980114A2 (en) 1998-12-31
JP2001513796A (ja) 2001-09-04
KR20000075907A (ko) 2000-12-26
EP0966463A1 (en) 1999-12-29
NO994303D0 (no) 1999-09-03
GB9704498D0 (en) 1997-04-23
CO4940415A1 (es) 2000-07-24
AP9901637A0 (en) 1999-09-30
ZA981791B (en) 1999-09-03
CA2282851A1 (en) 1998-09-11
WO1998039327A1 (en) 1998-09-11
AR011178A1 (es) 2000-08-02
YU43499A (sh) 2000-12-28

Similar Documents

Publication Publication Date Title
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
TR200201668T2 (tr) Vla-4' e bağlı hücre bağlamasının peptidilsiz önleyicileri
TR200000059T2 (tr) Piridin türevleri
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
GB9801690D0 (en) Therapeutic agents
SE9504661D0 (sv) New compounds
DE69801048D1 (de) Fungizide trifluorophenyl-triazolopyrimidine
DK274788D0 (da) Tetrazoler
ZA988158B (en) Sulfinic acid derivatives and their preparation and use
BR0112367A (pt) Forma cristalina alfa do sal de terc-butilamina do perindopril
TR200002605T2 (tr) Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
ES2181853T3 (es) Tratamiento del tinnitus empleando agentes neuroprotectores.
EP1140900A4 (en) PYRAZOLE COMPOUNDS AND USE OF SUCH COMPOUNDS
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
TR200002580T2 (tr) Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler
DK0782567T3 (da) Isothiourinstofderivater og fremgangsmåder til deres fremstilling
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
ATE224372T1 (de) Substituierte 6-alkylphenanthridine
TR199902117T2 (xx) (E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-�ndol-2-karboksilik asidin kristalimsi hidratlanm�� sodyum tuzu.
SE9504662D0 (sv) New compounds
ID16479A (id) Senyawa-senyawa pengobatan
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.